Invest in O'Reilly Automotive after 15-for-1 stock split, avoid Regencell Bioscience Holdings.
From Nasdaq.: 2025-07-01 03:51:00
- Stock splits have been a key factor in driving the stock market to record highs, alongside artificial intelligence innovations on Wall Street.
- Forward stock splits are preferred by investors as they make shares more affordable and have historically outperformed the S&P 500.
- O’Reilly Automotive, with its recent 15-for-1 forward split, presents a solid investment opportunity due to its recession-resistant business model and long-term growth potential.
- Regencell Bioscience Holdings, on the other hand, faces challenges as a clinical-stage company with limited commercialization prospects, making it a risky investment.
- Consider investing in the 10 best stocks recommended by the Motley Fool Stock Advisor team for potential high returns, excluding O’Reilly Automotive from the list.
- Bank of America research shows companies completing forward splits have averaged a 25.4% return in the 12 months following their announcement, outperforming the S&P 500.
Read more at Nasdaq.: 1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid